Lisa S. Parker
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Lisa S. Parker has a total of 152 co-authors. Here are the top co-authors by number of shared publications:
- Alex John London
Philosophy Department, Carnegie Mellon University, Pittsburgh, PA, USA
3 shared publications - Nagendra Mishra
Assistant Professor and HOD, Dept. of Psychology, LS College, Muzaffarpur, Bihar, INDIA
3 shared publications - Robin E. Grubs
Department of Human Genetics, University of Pittsburgh, Pittsburgh, PA, USA
3 shared publications - Arjun Prabhu
A University of Pittsburgh School of Medicine
2 shared publications Barbara A. Koenig
University of California–San Francisco, San Francisco, California, USA
2 shared publicationsBenjamin S. Wilfond
University of Washington, Seattle, Washington, USA
2 shared publications
Latest Publications
- 4 August 2026
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 47 (10) , 973-978
Pathogen genomic surveillance in health care: emerging ethical dilemmas in outbreak detection and patient notification
Genomic surveillance detects healthcare-associated outbreaks that are often missed by traditional methods, offering substantial benefits for infection prevention. However, its use introduces complex ethical questions regarding patient notification and disparities in outbreak detection between institutions with and without genomic capabilities. In this commentary, we apply the Centers for Disease Control and Prevention’s 2020 ethical considerations regarding patient notification and the Ethical Infection Prevention and Control (EIPAC) framework to two hypothetical scenarios involving genomic surveillance programs. We identify ethical justifications for patient notification when both genomic and epidemiologic evidence suggest transmission, as well as considerations militating for and against notification when epidemiologic evidence supporting genomic findings is absent. Our analysis, informed by qualitative research reporting the types of harm experienced by patients across detected and undetected outbreaks, includes a matrix illustrating physical, psychological, and ethical harms associated with different detection and disclosure conditions. We also discuss ethical concerns arising from institutional disparities in genomic capability such that patients in hospitals without genomic surveillance may suffer preventable harm and remain uninformed due to lack of detection. We recognize that hospitals adopting genomic surveillance face new ethical duties to disclose transmission events, while those that do not engage in such surveillance risk perpetuating inequities in patient safety and transparency. We argue that national guidance is needed to ensure consistency in notification and promote ethical use of genomics. Coordinated frameworks from professional societies should define genetic thresholds warranting disclosure, address disparities in pathogen genomic detection methods, and uphold patient trust in the genomic era.
- 4 August 2026
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 47 (10) , 973-978
Pathogen genomic surveillance in health care: emerging ethical dilemmas in outbreak detection and patient notification
Genomic surveillance detects healthcare-associated outbreaks that are often missed by traditional methods, offering substantial benefits for infection prevention. However, its use introduces complex ethical questions regarding patient notification and disparities in outbreak detection between institutions with and without genomic capabilities. In this commentary, we apply the Centers for Disease Control and Prevention’s 2020 ethical considerations regarding patient notification and the Ethical Infection Prevention and Control (EIPAC) framework to two hypothetical scenarios involving genomic surveillance programs. We identify ethical justifications for patient notification when both genomic and epidemiologic evidence suggest transmission, as well as considerations militating for and against notification when epidemiologic evidence supporting genomic findings is absent. Our analysis, informed by qualitative research reporting the types of harm experienced by patients across detected and undetected outbreaks, includes a matrix illustrating physical, psychological, and ethical harms associated with different detection and disclosure conditions. We also discuss ethical concerns arising from institutional disparities in genomic capability such that patients in hospitals without genomic surveillance may suffer preventable harm and remain uninformed due to lack of detection. We recognize that hospitals adopting genomic surveillance face new ethical duties to disclose transmission events, while those that do not engage in such surveillance risk perpetuating inequities in patient safety and transparency. We argue that national guidance is needed to ensure consistency in notification and promote ethical use of genomics. Coordinated frameworks from professional societies should define genetic thresholds warranting disclosure, address disparities in pathogen genomic detection methods, and uphold patient trust in the genomic era.
- Open Access
- 19 March 2026
- Published by IOP Publishing in Journal of Neural Engineering
- Vol. 23 (2)
Solving the problem of inception: A cross-species perspective on strategies for a mechanistic refinement of intracortical microstimulation
Microstimulation delivers electrical pulses directly into the brain, with one of its promises being to restore lost senses to millions of people. Yet a fundamental challenge remains: how do intracortical microstimulation (ICMS) patterns engage neural circuits to achieve the inception of specific experiences, such as vivid sensory percepts of touch and vision? Here, we define “inception” as the initiation of percepts evoked by microstimulation through the mapping of stimulation to circuit-level activity that results in sensory experiences. This perspective proposes an integrated research framework that combines Reverse Translation, Forward Translation, and computational neuroscience to bridge insights between clinical observations and high-resolution animal studies. Our framework envisions the development and evaluation of ICMS strategies within a cross-species system that narrows the range of plausible underlying neural mechanisms and the set of evoked perceptual outcomes. Reverse Translation uses human perceptual reports about phosphenes, tones, and touch to guide investigations in rodents and non-human primates (NHPs), mapping the cell types and circuits underlying each percept. Forward Translation leverages these biological insights to design refined ICMS protocols for selective circuit engagement. Bidirectional Translation weaves these approaches together through computational neuroscience, ensuring that experimental observations iteratively and continuously refine one another across species and experimental modalities. This integrated strategy aims to transform microstimulation research into a dynamic dialogue between fundamental science and human experience. Harnessing the Bidirectional Translation Framework can accelerate therapies that enhance quality of life for people with sensory or motor impairments, and contribute more broadly to systems neuroscience by uncovering the mechanisms by which causal manipulation changes activity in neurons and networks.
- 19 March 2026
- Published by IOP Publishing in Journal of Neural Engineering
- Vol. 23 (2)
Open AccessSolving the problem of inception: A cross-species perspective on strategies for a mechanistic refinement of intracortical microstimulation
Microstimulation delivers electrical pulses directly into the brain, with one of its promises being to restore lost senses to millions of people. Yet a fundamental challenge remains: how do intracortical microstimulation (ICMS) patterns engage neural circuits to achieve the inception of specific experiences, such as vivid sensory percepts of touch and vision? Here, we define “inception” as the initiation of percepts evoked by microstimulation through the mapping of stimulation to circuit-level activity that results in sensory experiences. This perspective proposes an integrated research framework that combines Reverse Translation, Forward Translation, and computational neuroscience to bridge insights between clinical observations and high-resolution animal studies. Our framework envisions the development and evaluation of ICMS strategies within a cross-species system that narrows the range of plausible underlying neural mechanisms and the set of evoked perceptual outcomes. Reverse Translation uses human perceptual reports about phosphenes, tones, and touch to guide investigations in rodents and non-human primates (NHPs), mapping the cell types and circuits underlying each percept. Forward Translation leverages these biological insights to design refined ICMS protocols for selective circuit engagement. Bidirectional Translation weaves these approaches together through computational neuroscience, ensuring that experimental observations iteratively and continuously refine one another across species and experimental modalities. This integrated strategy aims to transform microstimulation research into a dynamic dialogue between fundamental science and human experience. Harnessing the Bidirectional Translation Framework can accelerate therapies that enhance quality of life for people with sensory or motor impairments, and contribute more broadly to systems neuroscience by uncovering the mechanisms by which causal manipulation changes activity in neurons and networks.
- Top Cited PapersOpen Access
- 3 June 2024
- Published by Association for Computing Machinery (ACM)
- p. 2033-2046
Responsible Adoption of Generative AI in Higher Education: Developing a “Points to Consider” Approach Based on Faculty Perspectives
This paper proposes an approach to the responsible adoption of generative AI in higher education, employing a “points to consider” approach that is sensitive to the goals, values, and structural features of higher education. Higher education's ethos of collaborative faculty governance, pedagogical and research goals, and embrace of academic freedom conflict, the paper argues, with centralized top-down approaches to governing AI that are common in the private sector. The paper is based on a semester-long effort at the University of Pittsburgh which gathered and organized perspectives on generative AI in higher education through a collaborative, iterative, interdisciplinary process that included recurring group discussions, three standalone focus groups, and an informal survey. The paper presents insights drawn from this effort—that give rise to the “points to consider” approach the paper develops. These insights include the benefits and risks of potential uses of generative AI In higher education, as well as barriers to its adoption, and culminate in the six normative points to consider when adopting and governing generative AI in institutions of higher education.
- 3 June 2024
- Published by Association for Computing Machinery (ACM)
- p. 2033-2046
Top Cited PapersOpen AccessResponsible Adoption of Generative AI in Higher Education: Developing a “Points to Consider” Approach Based on Faculty Perspectives
This paper proposes an approach to the responsible adoption of generative AI in higher education, employing a “points to consider” approach that is sensitive to the goals, values, and structural features of higher education. Higher education's ethos of collaborative faculty governance, pedagogical and research goals, and embrace of academic freedom conflict, the paper argues, with centralized top-down approaches to governing AI that are common in the private sector. The paper is based on a semester-long effort at the University of Pittsburgh which gathered and organized perspectives on generative AI in higher education through a collaborative, iterative, interdisciplinary process that included recurring group discussions, three standalone focus groups, and an informal survey. The paper presents insights drawn from this effort—that give rise to the “points to consider” approach the paper develops. These insights include the benefits and risks of potential uses of generative AI In higher education, as well as barriers to its adoption, and culminate in the six normative points to consider when adopting and governing generative AI in institutions of higher education.
- 1 September 2022
- Published by Project MUSE in Perspectives in Biology and Medicine
- Vol. 65 (4) , 680-693
Bioethics in the Current Climate
Drawing on insights from feminist epistemology and experience in genomics-related bioethics research, this essay offers three suggestions that may enable bioethics to contribute more persuasively to urgent issues affecting the health and well-being of individuals, communities, and the world they inhabit. First, it suggests that bioethics pay more attention to people's feelings, particularly those that help constitute their self-identities, and to the role of those feelings in their health-relevant behaviors. Further, it proposes conceiving of health-relevant behaviors expansively. Second, it suggests that bioethics advocate for a longer time horizon for the conduct of empirical bioethics research and other types of research addressing complex, systemic factors influencing health. Third, it suggests that bioethics play a larger role in illuminating and applauding the evolving nature of scientific knowledge.
- 1 September 2022
- Published by Project MUSE in Perspectives in Biology and Medicine
- Vol. 65 (4) , 680-693
Bioethics in the Current Climate
Drawing on insights from feminist epistemology and experience in genomics-related bioethics research, this essay offers three suggestions that may enable bioethics to contribute more persuasively to urgent issues affecting the health and well-being of individuals, communities, and the world they inhabit. First, it suggests that bioethics pay more attention to people's feelings, particularly those that help constitute their self-identities, and to the role of those feelings in their health-relevant behaviors. Further, it proposes conceiving of health-relevant behaviors expansively. Second, it suggests that bioethics advocate for a longer time horizon for the conduct of empirical bioethics research and other types of research addressing complex, systemic factors influencing health. Third, it suggests that bioethics play a larger role in illuminating and applauding the evolving nature of scientific knowledge.
- 25 July 2022
- Published by Springer Nature in Behavior Research Methods
- Vol. 55 (5) , 2333-2352
A new paradigm for investigating real-world social behavior and its neural underpinnings
Eye tracking and other behavioral measurements collected from patient-participants in their hospital rooms afford a unique opportunity to study natural beh
- 25 July 2022
- Published by Springer Nature in Behavior Research Methods
- Vol. 55 (5) , 2333-2352
A new paradigm for investigating real-world social behavior and its neural underpinnings
Eye tracking and other behavioral measurements collected from patient-participants in their hospital rooms afford a unique opportunity to study natural beh
- Open Access
- 6 July 2021
- Published by S. Karger AG in Public Health Genomics
- Vol. 24 (5-6) , 241-252
Practices and Attitudes toward Returning Genomic Research Results to Low-Resource Research Participants
Introduction: Many research programs are challenged to accommodate low-resource research participants’ (LRRP) ancillary care needs when returning genomic research results. We define LRRP as those who are low income, uninsured, underinsured, or facing barriers to act upon the results returned. This study evaluates current policies and practices surrounding return of results (RoR) to LRRP, as well as the attitudes of investigators toward providing ancillary care to LRRP. Methods: A semi-structured interview study was conducted with representatives of 35 genomic research programs nationwide. Eligible programs were returning, or planning to return, medically actionable genomic results to participants. Results: Three content categories emerged from this study, including: (1) RoR structures, (2) barriers to RoR to LRRP, and (3) solutions to meet community and LRRP needs. Three major structures of RoR emerged: (1) RoR Embedded in Clinical Care, (2) RoR Independent of Clinical Care, and (3) Reliance on Clinical Partnerships to Facilitate RoR. Inadequacy of program resources to address the needs of LRRP was commonly considered a significant obstacle. The attitudes and views of informants regarding responsibility to provide ancillary care for LRRP receiving genomic results were highly varied. Some informants believed that genomic sequencing and testing was not a priority for LRRP because of other pressing issues in their lives, such as housing and food insecurity. Research programs differ regarding whether clinical and social support for LRRP is considered within the purview of the research team. Some programs instituted accommodations for LRRP, including social work referral and insurance enrollment assistance. Conclusion: Support to access downstream treatment is not readily available for LRRP in many genomic research programs. Development of best practices and policies for managing RoR to LRRP is needed.
- 6 July 2021
- Published by S. Karger AG in Public Health Genomics
- Vol. 24 (5-6) , 241-252
Open AccessPractices and Attitudes toward Returning Genomic Research Results to Low-Resource Research Participants
Introduction: Many research programs are challenged to accommodate low-resource research participants’ (LRRP) ancillary care needs when returning genomic research results. We define LRRP as those who are low income, uninsured, underinsured, or facing barriers to act upon the results returned. This study evaluates current policies and practices surrounding return of results (RoR) to LRRP, as well as the attitudes of investigators toward providing ancillary care to LRRP. Methods: A semi-structured interview study was conducted with representatives of 35 genomic research programs nationwide. Eligible programs were returning, or planning to return, medically actionable genomic results to participants. Results: Three content categories emerged from this study, including: (1) RoR structures, (2) barriers to RoR to LRRP, and (3) solutions to meet community and LRRP needs. Three major structures of RoR emerged: (1) RoR Embedded in Clinical Care, (2) RoR Independent of Clinical Care, and (3) Reliance on Clinical Partnerships to Facilitate RoR. Inadequacy of program resources to address the needs of LRRP was commonly considered a significant obstacle. The attitudes and views of informants regarding responsibility to provide ancillary care for LRRP receiving genomic results were highly varied. Some informants believed that genomic sequencing and testing was not a priority for LRRP because of other pressing issues in their lives, such as housing and food insecurity. Research programs differ regarding whether clinical and social support for LRRP is considered within the purview of the research team. Some programs instituted accommodations for LRRP, including social work referral and insurance enrollment assistance. Conclusion: Support to access downstream treatment is not readily available for LRRP in many genomic research programs. Development of best practices and policies for managing RoR to LRRP is needed.
- 1 February 2019
- Published by Elsevier in Genetics in Medicine
- Vol. 21 (2) , 505-509
Normative and conceptual ELSI research: what it is, and why it’s important
- 1 February 2019
- Published by Elsevier in Genetics in Medicine
- Vol. 21 (2) , 505-509
Normative and conceptual ELSI research: what it is, and why it’s important
- 1 November 2018
- Published by Elsevier in Social Science & Medicine
- Vol. 216, 74-80
‘Recurrent losers unite’: Online forums, evidence-based activism, and pregnancy loss
- 1 November 2018
- Published by Elsevier in Social Science & Medicine
- Vol. 216, 74-80
‘Recurrent losers unite’: Online forums, evidence-based activism, and pregnancy loss
- Open Access
- 13 October 2018
- Published by Forum for Medical Ethics Society in Indian Journal of Medical Ethics
- Vol. III (4) , 315-320
A qualitative study of Institutional Ethics Committees: Members’ understanding of research guidelines, privacy, and challenges to privacy protection
...
- 13 October 2018
- Published by Forum for Medical Ethics Society in Indian Journal of Medical Ethics
- Vol. III (4) , 315-320
Open AccessA qualitative study of Institutional Ethics Committees: Members’ understanding of research guidelines, privacy, and challenges to privacy protection
...
- 1 July 2017
- Published by Elsevier in Genetics in Medicine
- Vol. 19 (7) , 743-750
The Precision Medicine Initiative’s All of Us Research Program: an agenda for research on its ethical, legal, and social issues
- 1 July 2017
- Published by Elsevier in Genetics in Medicine
- Vol. 19 (7) , 743-750
The Precision Medicine Initiative’s All of Us Research Program: an agenda for research on its ethical, legal, and social issues